Alexandra Schiettekatte, Author at BioWin

Webinaire EFS Santé – BioWin

Retour sur le webinaire EFS Santé - BioWin 14 septembre 2022 Découverte des services de l'EFS Santé pour vos activités de recherche & innovation. Opérateur civil unique de la transfusion sanguine en France, l’EFS a pour mission principale l’autosuffisance nationale en produits sanguins. EFS s’investit par ailleurs dans de...

Alexandra Schiettekatte In BioWin events, Life Science events, Partner events

BioEurope Fall 2022

Join Awex and BioWin at BioEurope Fall! Awex is organizing, in collaboration with BioWin, an information stand at the BIO-Europe Fall congress which will take place from October 24 to 26, 2022, at the Messe in Leipzig. This international event for the healthcare biotechnology and pharmaceutical sector offers the opportunity...

Alexandra Schiettekatte In Life Science events

EU-Japan Biotech & Pharma Partnering Conference 2022

EU-Japan Biotech & Pharma Partnering Conference 2022 Hybrid Event - Online from 26-30 September 2022 - Onsite Partnering on 11 October 2022 in Osaka, Hotel Hankyu International The EU-Japan Biotech & Pharma Partnering Conference 2022 offers business contacts to industry professionals who are looking for potential partners in the Biotech...

Alexandra Schiettekatte In Life Science events, Partner events

Science for Health

Conference Science for Health Advancing Gene Therapy 21 November 2022 SQUARE Brussels and online Gene therapy could enable patients to live without the need for ongoing treatments or the burden of daily disease management. How are we turning this promise into reality? Join us for the latest insights from...

Alexandra Schiettekatte In BioWin events, Life Science events

WEBINAIRE EFS Santé -BioWin

Que peut l’EFS faire pour vos activités de recherche? Découvrez-le pendant une séance d’information sous forme de webinaire virtuel le 14 septembre. Réservé aux membres de BioWin. Opérateur civil unique de la transfusion sanguine en France, l’EFS a pour mission principale l’autosuffisance nationale en produits sanguins. EFS s’investit par ailleurs...

Alexandra Schiettekatte In Life Science events, Partner events

Bioproduction vol.10 Continuum for Biologics

Event: Bioproduction vol.10 Continuum for Biologics, powered by Buzz4Bio & Brussels South BioPark. When? 28-29 septembre Where? Charleroi, Brussels South BioPark _____________________________________________ The 10th edition of this event is fully focused on the Continuum for Biologics. For whom? All players involved in Bioproduction focused on R&D, provider of solutions, suppliers...

Alexandra Schiettekatte In All events, Life Science events

Advanced Therapy Showcase #3 (ATST)

Wednesday, February 1, 2023, JST One-on-One Business Meetings: Monday, January 30 ~ Friday, February 3, 2023, JST Life Science Innovation Network Japan (LINK-J) launched the partnering event series "Advanced Therapy Showcase in Tokyo (ATST)" in January 2021. Following the two successful events, Link-J is pleased to announce that the...

Alexandra Schiettekatte In Life Science events

HealthTech Innovation Days – HTID4

The HealthTech Innovation Days , organized by HealthTech For Care, are organized on October 12 (digital only) and October 13 & 14 in Paris and virtually. Use the following promotional code to get a 15% discount 👉 HTID4-15 (only for BioWin members) ❓What you will get: • Private meetings: To...

Alexandra Schiettekatte In Life Science events

Webinar: Investor Perspective – The Strategic Venturing Spectrum

WEBINAR Investor Perspective: The Strategic Venturing Spectrum June 7, 2022 | Virtual 16:00 - 17:00 CEST ORGANIZED BY JOHNSON & JOHNSON INNOVATION Is your startup interested in access to Corporate Venture Capital (CVC)? You may be more successful in landing an investment if you learn to look from their...

Alexandra Schiettekatte In Blogs

ESG for Pharmaceuticals and Life Sciences (3)

SERIES on ESG in collaboration with PWC Why ESG is critical in IPO communications ? Discover more in PWC’s latest reports! You never get a second chance to make a first impression - Why ESG is critical in IPO communications - Companies looking to access capital via IPO's need to...